Skip to main content

Proguanylin and prouroguanylin--assay evaluation and clinical analyte characterization.

Kaar G, Dieplinger B, Gabriel C, Haltmayer M, Mueller T

Publication: Clin Chim Acta (2011) • Vol 412 • Page 2277-83PMID: 21888901View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage duration at -80 degrees C on the levels of proguanylin and prouroguanylin in plasma.

Conclusion

Storage for 2 months at -80 degrees C did not affect proguanylin or prouroguanylin concentrations in EDTA-plasma. Males had higher levels of proguanylin than females (7.4 ng/mL versus 6.8 ng/mL, p=0.011), but gender had no effect on levels of prouroguanylin. In addition, patient age had no effects on levels of proguanylin or prouroguanylin.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage duration at -80 degrees C on the levels of proguanylin and prouroguanylin in plasma. EDTA-plasma was diluted 5-fold prior to measurement. Inter- and intra-individual variability were determined among specimens that were collected weekly, from 22 healthy individuals, in a seated position, between 8 and 10 AM. Gender and age differences were determined using specimens from 125 blood donors.

Summary of Findings

Storage for 2 months at -80 degrees C did not affect proguanylin or prouroguanylin concentrations in EDTA-plasma. The intraindividual coefficients of variance (CV) were 9% for proguanylin and 21% for prouroguanylin, and the interindividual variabilities were 30% for proguanylin and 26% for prouroguanylin. Males had higher levels of proguanylin than females (7.4 ng/mL versus 6.8 ng/mL p=0.011), but gender had no effect on levels of prouroguanylin. In addition, patient age had no effects on levels of proguanylin or prouroguanylin.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
    Normal
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPatient age
    18-65 years
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionTime of biospecimen collection
    Week 1
    Week 2
    Week 3
    Week 4
    Week 5
    Week 6
    Biospecimen Aliquots and ComponentsBiospecimen components
    10.5 ng/mL proguanylin
    13.6 ng/mL prouroguanylin
    24.9 ng/mL proguanylin
    7.0 ng/mL prouroguanylin
    StorageStorage duration
    0 days
    1-20 days
    2 months